Newsletter 11/2012



Dear ###USER_title1### ###USER_last_name###,



Testing for rare hereditary diseases is becoming more important but also a common diagnostic tool, especially as newer and more effective options for the treatment of certain diseases have become available.

Most insurance carriers cover genetic testing services. But each situation is unique. If a patient is uninsured or unable to cover the costs otherwise, Centogene is offering genetic and biochemical testing at no charge on a research basis through our Centogene Charity Testing Program (CCTP).

To qualify for our program, the CCTP application form (download pdf) has to be properly completed and submitted. A short review process by a Centogene expert committee is guaranteed to ensure that no time is lost that can seriously impact the patient’s quality of life. 

At Centogene, we are dedicated to offer the greatest medical benefit to every patient.
This is always at the forefront of all our activities.

For any questions or comments arised, do not hesitate to contact us anytime.

Best regards,

Doreen Niemann
Senior Director Strategic Communication
Centogene AG


Centogene AG
Schillingallee 68
18057 Rostock


Responsible: Doreen Niemann
USt-IdNr.: DE813228872